These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37205327)

  • 1. A Novel Risk Assessment Model Predicts Major Bleeding Risk at Admission in Medical Inpatients.
    Mittman BG; Sheehan M; Kojima L; Cassachia N; Lisheba O; Hu B; Pappas M; Rothberg MB
    medRxiv; 2023 May; ():. PubMed ID: 37205327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Internal Validation of the Cleveland Clinic Bleeding Model to Predict Major Bleeding Risk at Admission in Medical Inpatients.
    Mittman BG; Sheehan M; Kojima L; Casacchia NJ; Lisheba O; Hu B; Pappas MA; Rothberg MB
    J Thromb Haemost; 2024 Jul; ():. PubMed ID: 39002732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators.
    Decousus H; Tapson VF; Bergmann JF; Chong BH; Froehlich JB; Kakkar AK; Merli GJ; Monreal M; Nakamura M; Pavanello R; Pini M; Piovella F; Spencer FA; Spyropoulos AC; Turpie AG; Zotz RB; Fitzgerald G; Anderson FA;
    Chest; 2011 Jan; 139(1):69-79. PubMed ID: 20453069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score.
    Hostler DC; Marx ES; Moores LK; Petteys SK; Hostler JM; Mitchell JD; Holley PR; Collen JF; Foster BE; Holley AB
    Chest; 2016 Feb; 149(2):372-9. PubMed ID: 26867833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population.
    Wilkinson KS; Sparks AD; Gergi M; Repp AB; Al-Samkari H; Thomas R; Roetker NS; Zakai NA
    Res Pract Thromb Haemost; 2024 May; 8(4):102441. PubMed ID: 38953050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.
    Zakai NA; Wilkinson K; Sparks AD; Packer RT; Koh I; Roetker NS; Repp AB; Thomas R; Holmes CE; Cushman M; Plante TB; Al-Samkari H; Pishko AM; Wood WA; Masias C; Gangaraju R; Li A; Garcia D; Wiggins KL; Schaefer JK; Hooper C; Smith NL; McClure LA
    J Thromb Haemost; 2024 Feb; 22(2):503-515. PubMed ID: 37918635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a retrospective single-center cohort study in Japan.
    Arakaki D; Iwata M; Terasawa T
    Thromb J; 2024 Mar; 22(1):31. PubMed ID: 38549086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of bleeding in patients being considered for venous thromboembolism prophylaxis.
    Sahoo S; Hayssen H; Englum B; Mayorga-Carlin M; Siddiqui T; Nguyen P; Kankaria A; Yesha Y; Sorkin JD; Lal BK
    J Vasc Surg Venous Lymphat Disord; 2023 Nov; 11(6):1182-1191.e13. PubMed ID: 37499868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.
    Zhou H; Hu Y; Li X; Wang L; Wang M; Xiao J; Yi Q
    J Atheroscler Thromb; 2018 Nov; 25(11):1091-1104. PubMed ID: 29540637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of venous thromboembolism and bleeding risk in medical patients receiving VTE prophylaxis.
    Tung EC; Yu SY; Shah K; Kinkade A; Tejani AM
    J Eval Clin Pract; 2020 Feb; 26(1):18-25. PubMed ID: 31282101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
    Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
    Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.
    Blondon M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Bounameaux H; Righini M; Nendaz M
    Thromb Haemost; 2018 Jan; 118(1):82-89. PubMed ID: 29304528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Risk Assessment Model for Venous Thromboembolism in Patients With Invasive Mechanical Ventilation.
    Lin J; Zhang Y; Lin W; Meng Y
    Cureus; 2022 Jul; 14(7):e27164. PubMed ID: 36017277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
    Rocher WD; Page T; Rocher M; Nel D
    S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External Validation of the Risk Assessment Model of Venous Thromboembolism in Multicenter Internal Medicine Inpatients.
    Chen X; Shi H; Chang J; Guo W; Yang Y; Wang Y; Pan L
    Clin Appl Thromb Hemost; 2024; 30():10760296241247205. PubMed ID: 38632943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the Khorana prediction score and Caprini risk assessment models for assessing the risk of venous thromboembolism in hospitalized patients with cancer: a retrospective case control study.
    Hu Y; Li X; Zhou H; Lin P; Zhang J; Huang D; Qi M; Tang Y; Yi Q; Liang Z; Wang M
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):454-460. PubMed ID: 32910201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Tool for the Prediction of Venous Thromboembolism in Pediatric Trauma Patients.
    Connelly CR; Laird A; Barton JS; Fischer PE; Krishnaswami S; Schreiber MA; Zonies DH; Watters JM
    JAMA Surg; 2016 Jan; 151(1):50-7. PubMed ID: 26422678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.
    Darzi AJ; Karam SG; Spencer FA; Spyropoulos AC; Mbuagbaw L; Woller SC; Zakai NA; Streiff MB; Gould MK; Cushman M; Charide R; Etxeandia-Ikobaltzeta I; Germini F; Rigoni M; Agarwal A; Morsi RZ; Akl EA; Iorio A; Schünemann HJ
    Blood Adv; 2020 Jun; 4(12):2557-2566. PubMed ID: 32542391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.